Company Overview and News

 
Facebook Removes More ISIS Content by Actively Looking for It - Bloomberg

4h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Why Twitter (TWTR) Might Surprise This Earnings Season

11h zacks
Investors are always looking for stocks that are poised to beat at earnings season Twitter, Inc. (TWTR - Free Report) may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
Upvote Downvote

 
5 Terrific Tech Stocks to Buy Ahead of Q1 Earnings

12h zacks
Some of the biggest tech names are slated to report earnings this week. These results come at a time when the technology sector is grappling with several crises which have sprung up at short intervals. Of the companies, slated to report earnings this week, Facebook, Inc. (FB) has had to battle the fallout of a data leak scandal. Meanwhile, Amazon.com, Inc. (AMZN) has been the target of several attacks from President Trump.
Upvote Downvote

 
Twitter's Rise From The Ashes

14h seekingalpha
Twitter this past year has seen increasingly strong financial fundamentals as well as user metrics, and, for the first time, long-eluded profitability.
Upvote Downvote

 
Twitter’s Biz Stone invests in Delhi-based healthcare startup Visit

2018-04-22 livemint
New Delhi: Twitter Inc. co-founder Biz Stone has invested in his “personal capacity” in a Delhi-based health startup that uses an artificial intelligence-based bot in its app as he wants to contribute to a future where AI is seen as a “positive enhancement of humanity”. Founded in 2016, Visit is an on-demand healthcare service online platform which provides its users a pool of medical specialists and general physicians to choose from for consultation.
Upvote Downvote

 
Facebook, Amazon, Alphabet and More Top Earnings to Watch For This Week

2018-04-22 247wallst
The U.S. broad markets pushed forward this past week, marking the second consecutive week with a gain. Not to say that this has been entirely the result of earnings, but it’s been a big help, along with a strong push in crude oil as well. If we continue to see solid fundamentals from company earnings, markets should continue to rise. This is perhaps one of the busiest weeks for earnings of the year with a lot of big names coming quick.
Upvote Downvote

 
Stocks To Watch: Earnings Blockbusters And Trump Talks Drug Prices

2018-04-21 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
Upvote Downvote

 
Senators Press Google and Twitter for Answers on Privacy - Bloomberg

2018-04-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Twitter bans ads from Russia's Kaspersky Lab

2018-04-20 reuters
(Reuters) - Twitter Inc said on Friday that it has banned ads from Russia’s Kaspersky Lab, charging that the company’s business model conflicts with the social media platform’s advertising rules and citing U.S. claims that the firm has ties to Russian intelligence agencies.
Upvote Downvote

 
Twitter’s push into live-streaming starts to pay off as niche hits its stride

2018-04-20 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
Upvote Downvote

 
Facebook (FB) to Maintain its Stellar Earnings Streak in Q1?

2018-04-20 zacks
Facebook (FB - Free Report) is set to report its first-quarter 2018 results on Apr 25. The company remained in the spotlight throughout the quarter for a number of reasons and its results are thus highly awaited. In mid-March, when the company’s data misuse allegations surfaced, it captured the attention of worldwide regulators instantaneously. The incident wreaked havoc not only on the stock but also on the technology sector, bringing the entire sector down in the last few days of the quarter.
Upvote Downvote

 
Can Twitter (TWTR) Deliver a Beat This Earnings Season?

2018-04-20 zacks
Twitter (TWTR - Free Report) is set to report first-quarter 2018 results on Apr 25. We believe the company’s strength in video advertising coupled with focus on live video streaming will boost top-line growth. Earnings Trend Impressive The company beat the Zack Consensus Estimate in all the trailing four quarters, delivering an average positive surprise of 153.10%. In the last reported quarter, Twitter posted non-GAAP earnings per share of 19 cents, which came ahead of the Zacks Consensus Estimate of 14 cents per share and increased 72.
Upvote Downvote

 
Top Analyst Upgrades and Downgrades: Alcoa, Apple, Amazon, Facebook, Kinder Morgan, Philip Morris, P&G, Twitter, Williams Companies and Many More

2018-04-20 247wallst
Stocks were indicated to open marginally lower on Friday morning, but that may be a lack of direction after close to a 2% gain this week in the Dow Jones industrial average and S&P 500. Some investors have been rethinking what the nine-year bull market may bring in 2018 and beyond. After all, the trend of buying pullbacks has become more vulnerable to sellers, volatility and each major news headline.
Upvote Downvote

 
Twitter upgraded to buy at MKM partners; shares up 2% in premarket - MarketWatch

2018-04-20 marketwatch
Twitter Inc. TWTR, +0.00% was upgraded to buy from neutral on Friday by analysts at MKM Partners, who said the online news and social networking service is "here to stay and still has mass market potential." MKM analyst Rob Sanderson said he's encouraged by Twitter's rebound in user growth with daily active user (DAU) growth up by double digits for five quarters. "We think the stock is a buy on upside from monetization gains, but that the uber-bull case that TWTR eventually reaches the mainstream market is still on the table," said Sanderson in a note to clients.
Upvote Downvote

 
Twitter upgraded to buy at MKM partners; shares up 2% in premarket - MarketWatch

2018-04-20 marketwatch
Twitter Inc. TWTR, +0.00% was upgraded to buy from neutral on Friday by analysts at MKM Partners, who said the online news and social networking service is "here to stay and still has mass market potential." MKM analyst Rob Sanderson said he's encouraged by Twitter's rebound in user growth with daily active user (DAU) growth up by double digits for five quarters. "We think the stock is a buy on upside from monetization gains, but that the uber-bull case that TWTR eventually reaches the mainstream market is still on the table," said Sanderson in a note to clients.
Upvote Downvote

TWTR : Twitter Stock Analysis and Research Report

2017-11-04 - Asif

Twitter is the best and fastest place to see what is happening and what people are talking about all around the world. Every day, instances of breaking news, entertainment, sports, politics, big events and everyday interests happen first on Twitter. Twitter is where the full story unfolds with all the live commentary and where live events come to life unlike anywhere else. The company's primary service can be accessed on a variety of mobile devices, at twitter.com and via SMS. In 2016, the company focused on positioning Twitter for long-term sustainable growth and making progress toward GAAP profitability. Specifically, the company clearly identified who Twitter is—the best and fastest place to see what’s happening in the world and what people are talking about. The company built and shipped product features that directly improved its key audience growth and engagement metrics. The company also simplified the organization to be what the company believe is more focused and efficient...

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

8h - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

CUSIP: 90184L102